CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 90 filers reported holding CARIBOU BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,688,505 | +61.4% | 1,817,679 | +43.5% | 0.00% | 0.0% |
Q2 2023 | $5,383,617 | -18.8% | 1,266,733 | +1.4% | 0.00% | 0.0% |
Q1 2023 | $6,633,507 | -14.1% | 1,249,248 | +1.6% | 0.00% | 0.0% |
Q4 2022 | $7,719,168 | -39.8% | 1,229,167 | +1.2% | 0.00% | -50.0% |
Q3 2022 | $12,815,000 | +266.9% | 1,214,592 | +88.8% | 0.00% | – |
Q2 2022 | $3,493,000 | +87.5% | 643,183 | +217.0% | 0.00% | – |
Q1 2022 | $1,863,000 | +19.7% | 202,888 | +96.8% | 0.00% | – |
Q4 2021 | $1,556,000 | +23.6% | 103,068 | +95.4% | 0.00% | – |
Q3 2021 | $1,259,000 | – | 52,756 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
72 Investment Holdings, LLC | 474,067 | $2,266,040 | 15.18% |
Elmwood Wealth Management, Inc. | 2,364,415 | $11,301,904 | 5.45% |
PFM Health Sciences, LP | 6,724,715 | $32,144,138 | 1.51% |
SILVERARC CAPITAL MANAGEMENT, LLC | 892,786 | $4,267,517 | 1.29% |
Avidity Partners Management LP | 6,050,212 | $28,920,013 | 1.16% |
Paradigm Biocapital Advisors LP | 2,944,513 | $14,074,772 | 0.96% |
Kynam Capital Management, LP | 1,068,527 | $5,107,559 | 0.84% |
Green Alpha Advisors, LLC | 110,524 | $528,305 | 0.41% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,500,000 | $16,730,000 | 0.37% |
Bruce & Co., Inc. | 200,000 | $956,000 | 0.33% |